Since they are discontinuing their interpretation of the data, they should just open source the interpretation engine and dataset. People still have to pay the

Since they are discontinuing their interpretation of the data, they should just open source the interpretation engine and dataset. People still have to pay the $99 for the tests to get the data to interpret, so it wouldn't harm their business. It would keep their service out of the FDA's crosshairs, while keeping the service as useful as ever. In fact, it would likely improve it over what it will become with this latest development.